Description Inotuzumab Ozogamicin, marketed under the brand name BESPONSA, It is an prescription medication that has been approved inotuzumab ozogamicin (Besponsa) on August 17, 2017, for treating adults with B-cell acute lymphoblastic leukemia (ALL) that is relapsed or refractory. The FDA approved inotuzumab ozogamicin for pediatric patients on March 6, 2024, for treating c What is BESPONSA (Inotuzumab ozogamicin) ? BESPONSA is a CD22-directed antibody-drug conjugate (ADC) indicated for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). Source Content From US FDA How to order approved “BESPONSA (Inotuzumab ozogamicin) for injection” Medicine? BESPONSA (Inotuzumab Ozogamicin) Injection is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing BESPONSA and arranging delivery to your location, please get in touch with Mr. Rakesh at 91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
